Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

Cardiologists reflect on developing primary PCI in face of criticism and pushback
SCAI celebrated cardiologists William W. O'Neill, MD, and Cindy L. Grines, MD, for the important roles they played in the development of primary PCI. “It was challenging,” Grines explained. “We had the pharmaceutical industry that was anti-primary angioplasty and we had a lot of our own colleagues that were anti-primary angioplasty."
How TAVR valve choice impacts outcomes when treating type 1 bicuspid AS
Self-expanding and balloon-expandable TAVR valves are associated with comparable success rates and one-year outcomes when treating type 1 bicuspid aortic stenosis. However, each valve type comes with its own advantages and disadvantages.
IVUS-guided PCI reduces risks in patients with diabetes
PCI can be more challenging in high-risk patients presenting with diabetes and ACS. IVUS guidance was associated with improved outcomes among these patients compared to angiography guidance alone.
Medtronic using AI to identify more TAVR patients in need
Medtronic has launched new research into AI's potential to identify patients with severe aortic stenosis and other worrying symptoms. The company hopes to overcome longstanding health disparities and reach individuals who may otherwise go untreated.
SAVR linked to higher 10-year survival rate than TAVR for low-risk patients
TAVR patients in this study were treated with early-generation devices that have since been updated, but researchers still believe their data are relevant to today's care teams.

New guideline on mechanical circulatory support tackles device selection, ethical dilemmas and more

The Heart Failure Society of America and International Society for Heart and Lung Transplantation worked together on the document, hoping their recommendations serve as a "critical roadmap" for clinicians.

February 8, 2023

Ajay J. Kirtane, MD, director of the cardiac catheterization laboratories and professor of medicine at NewYork-Presbyterian/Columbia University Irving Medical Center, explains the current trial data on catheter renal denervation to treat drug-resistant hypertension at AHA 2022.

Where renal denervation stands for the treatment of drug-resistant hypertension

Ajay Kirtane, MD, director of the cardiac catheterization laboratories at NewYork-Presbyterian/Columbia University Irving Medical Center, explained the most recent clinical trial data on this topic.

February 8, 2023

Balloon expansion deployment of an Edwards Lifesciences Sapien 3 transcatheter aortic valve replacement (TAVR) device.

New Jersey hospital performs 4,000th TAVR procedure

Morristown Medical Center first started performing TAVR procedures in 2011 and is now home to one of the largest TAVR programs in the United States.

February 7, 2023

A transcatheter aortic valve replacement (TAVR) procedure being performed at Intermountain Healthcare. Image from Intermountain Healthcare

TAVR and PAD: What cardiologists need to know

TAVR patients presenting with peripheral artery disease face significantly higher in-hospital risks, according to a new study published in Current Problems in Cardiology.

February 6, 2023

Coronary IVL now recommended at all cath labs, even those without surgical backup

The latest SCAI guidance on the safety of PCI procedures included a key change that could expand coronary IVL utilization throughout the United States.

February 1, 2023

Why are post-TAVR stroke rates higher at comprehensive stroke centers?

One of the more likely reasons is simple: specialty centers have better tools for identifying signs of stroke.

February 1, 2023

CardiacSense, an Israel-based healthcare technology company, gained FDA clearance for its CSF-3 medical watch

Regulatory Roundup: FDA clears new medical watch, considers empagliflozin for CKD and much more

Our monthly review of FDA-related news items in the world of cardiology includes updates from CardiacSense, MedAlliance, Lupin, Realize Medical and Eli Lilly and Company.

January 31, 2023

Interventional cardiologists can safely perform PCI without on-site surgical backup

The finding comes from a new expert consensus statement published by the Society for Cardiovascular Angiography and Interventions. Several industry societies, including the ACC and AHA, have endorsed the document.

January 30, 2023

Around the web

Health Imaging

Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging

New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Interventional Cardiology

Cardiologists reflect on developing primary PCI in face of criticism and pushback

How TAVR valve choice impacts outcomes when treating type 1 bicuspid AS

IVUS-guided PCI reduces risks in patients with diabetes

Medtronic using AI to identify more TAVR patients in need

SAVR linked to higher 10-year survival rate than TAVR for low-risk patients

Around the web